Update of medically important yeasts and a practical approach to their identification

Laboratory Medicine

Volumn 38, Issue 3, 2007, Pages 178-183

  Fenn, Jo Ann Parker ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149467913     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/WFJEBPMDHV4EAT0J     Document Type: Review

References (35)

1. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev. JAMA. 1995;8:462-478.
2. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. 1996;275:189-193.
3. Ana Espinel-Ingroff A. Clinical relevance of fungal susceptibility testing & antifungal resistance. Clinical Microbiology Reviews. Sept. 15 2000:Vol 22.
4. Hazen KC, Howell, SA. Candida, Cryptococcus and other yeasts of medical importance. Manual of Clinical Micobiology, 8th Ed. Location: ASM Press; 2003:1693-1711.
5. Kiehn T, Sebti A, Sepkowitz KA, et al. Candida dubliniensis: An emerging pathogen. Clin Micro Newsletter. 2001;23:83-86.
6. Pfaller MA, Diekema DJ, Jones RN, et al. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with blood stream infections. SENTRY Antimicrobiol Surveillance Program 1997 to 2000. J Clin Microbiol. 2002;40:852-856.
7. Pfaller MA. Nosocomial Candidiasis: Emerging species, reservoirs, and modes of transmission. Clin Infect Dis. 1996;22: S89-S94.
8. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-1530.
9. Pfaller MA, Jones RN, Messer SA, et al. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurance and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Diagn Microbiol Infect Dis. 1998;30:121-129.
10. Pfaller MA, Jones RN, Messer SA, et al. National surveillance of nosocomial blood stream infections due to Candida albicans: Frequency of occurrance and antifungal susceptibility in the SCOPE Program. Diagn Micobiol Infect Dis. 1998;31:327-332.
11. Mizuta M, Blumberg EA. Impact of fungal infections on solid-organ transplant recipients. Clin Microbiol Newsletter. 2005;27:123-126.
12. Pfaller MA, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and invitro susceptibility to fluconozole, rariconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobiol Surveillance Program. J Clin Microbiol. 2001;39:3254-3257.
13. Pfaller MA, Diekema DJ. Mini Review-rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42:4419-4431.
14. Fidel PL, Vazquez JA, Sobel JD, et al. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Reviews. 1999;12:80-96.
15. Sullivan D, Coleman D. Candida dubliniensis: Characteristics and identification. J Clin Microbiol. 1998;36:329-334.
16. Jabra-Rizk MA, Falkler WA, Merz WG, et al. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clincal laboratory isolates from human immunodificiency virus (HIV-1)-infected and non-HIV infected individuals. J Clin Micorobiol. 2000;38:2423-2426.
17. Gales C, Pfaller MA, Houston AK, et al. Identification of Candida dubliniensis based on temperature and ulitization of xylose and methyl-D glucoside as determined with the API 20C Aux and Vitek YBC systems. J Clin Micobiol. 1999;37:3804-3808.
18. Sancak B, Rex JH, Paetznick, V, et al. Evaluation of a method for identification of Candida dubliniensis bloodstream isolates. J Clin Microbiol. 2003;41:489-491.
19. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, PA: Lea and Febiger; 1992:3-25,62,398-446,768-779.
20. Marcon MJ, Powell DA. Malassezia furfur. Clin Microbiol Newsletter. 1988;10:41-45.
21. Aucott, JN, Fayen J, Grossnicklas H, et al. Invasive infection with S. cerevisiae: Report of three cases and review. Reviews of Infectious Disease. 1990;12: 406-411.
22. Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clinical Infectious Dis. 2005;40:1625-1637.
23. Gueho E, Smith MT, De Hoog GS, et al. Contributions to a revision of the genus Trichosporon. Antonie van Leeuwenhock. 1992;61:289-316.
24. Herbrecht R, Koenig H, Waller J, et al. Trichosporon infections: Clinical manifestations and treatment. J Mycol Med. 1993:3:129-136
25. D'Antonio D, Mazzoni A, Iacone A, et al. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J Clin Microbiol. 1996;34:753-755.
26. Monheit JE, Cowan DF, Moore DG. Rapid detection of fungi in tissues using calcofluor white and fluorescence microscopy. Arch Pathol Lab Med. 1984;106:616.
27. Larone DH. Medically Important Fungi - A Guide to Identification. 4th Ed. Washington DC: ASM Press; 2002.
28. Haley LD and Callaway CS. Laboratory Methods in Medical Mycology. Atlanta, GA: US Department of Health, Education and Welfare, Public Health Service, Center for Disease Control;1978.
29. Gade W, Hinnefeld SW, Babcock LS, et al. Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol. 1991;29:1616-1619.
30. Frank UK, Nishimura SL, Li CN, et al. Evaluation of an enzyme immunoassay for dection of cyptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol. 1993:31:97-101.
31. Buschelman B, Jones RN, Pfaller MA, et al. Colony morphology of Candida spp. as a guide to species identification. Diagn Microbiol Infect Dis. 1999;35:89-91.
32. Pfaller MA, Houston A, Coffman S, et al. Application of CHROMagar candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol. 1996;34:58-61.
33. McGinnis MR. Laboratory Handbook of Medical Mycology. New York, NY: 1980;78-83.
34. Fenn JP, Billetdeaux E, Segal H, et al. Comparison of four methodologies for rapid and cost effective identification of Candida glabrata. J Clin Microbiol. 1999;37:3387-3389.
35. Fenn JP, Segal H, Barland B, et al. Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J Clin Microbiol. 1994;32:1184-1187.